BCM
MMSI icon

BlueCrest Capital Management’s Merit Medical Systems MMSI Stock Holding History

BlueCrest Capital Management’s Portfolio MMSI Stock Details MMSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,100
Closed -$229K – 277
2023
Q1 		$229K Buy
+3,100
New +$217K 0.01% 242
2017
Q3 		– Sell
-7,238
Closed -$276K – 1001
2017
Q2 		$276K Buy
+7,238
New +$242K 0.01% 710

Other funds holding MMSI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlueCrest Capital Management's MMSI Position: Q2 2023 in Review

BlueCrest Capital Management sold out of Merit Medical Systems (MMSI) in Q2 2023, closing a stake of 3,100 shares — an estimated $229K sold.

BlueCrest Capital Management first reported a position in MMSI in Q2 2017 and held it in 2 quarters. The position peaked at $276K in Q2 2017. 312 funds tracked by Wall St. Rank hold MMSI as of Q2 2023.

  • BlueCrest Capital Management reported no remaining Merit Medical Systems position as of Q2 2023 after selling out during the quarter.
  • BlueCrest Capital Management sold 3,100 Merit Medical Systems shares in Q2 2023, an estimated $229K.
  • BlueCrest Capital Management first reported a position in Merit Medical Systems in Q2 2017 and held it in 2 quarters.
  • BlueCrest Capital Management's Merit Medical Systems position peaked at $276K in Q2 2017.
  • 312 funds tracked by Wall St. Rank held Merit Medical Systems as of Q2 2023.

Based on BlueCrest Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.